БИОМЕДИЦИНСКИЙ ЖУРНАЛ МЕДЛАЙН.РУ
Содержание журнала

Архив

Редакция
Учредители

Федеральное государственное бюджетное учреждение «Научно-клинический центр токсикологии имени академика С.Н. Голикова Федерального медико-биологического агентства»


Федеральное государственное бюджетное учреждение науки
Институт теоретической и экспериментальной биофизики
Российской академии наук


ООО "ИЦ КОМКОН"

Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314


Клиническая медицина » Терапия • Неврология

Том: 6
Статья: « 167 »
Страницы:. 592-596
Опубликована в журнале: 0 г.

English version

Острая энцефалопатия, связанная с приемом препарата вальпроевой кислоты. Обзор литературы и клиническое наблюдение

Войтенков В.Б., Борисова Е.В.

ГУ НИИЭМ РАМН ( клиника, отделение неврологии), С.-Петербург,
П.С.Малый пр,13 (812) 235-26-80


Резюме



Ключевые слова




(статья в формате PDF. Для просмотра необходим Adobe Acrobat Reader)



открыть статью в новом окне

Список литературы

1. Zurh W, Rengeling M, Hackenberg K. Acute liver necrosis caused by valproate. Dtsch Med Wochenschr. 1985 Jun 14;110(24):956-9.


2. Papp Z et al., Anticonvulsant hypersensitivity syndrome. Orv Hetil. 2004 Aug 8;145 (32):1665-8.


3. Sztajnkrycer M.D. Valproic acid toxicity: overview and management.


4. Sinclair DB, Berg M, Breault R Valproic acid-induced pancreatitis in childhood epilepsy: case series and review. Child Neurol. 2004 Jul;19(7):498-502.


5. Perucca E Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.


6. Verrotti A, Greco R, Morgese G, Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.


7. Mallet L, Babin S, Morais JA, Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.


8. McCall M, Bourgeois JA. Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol. 2004 Oct;24(5):521-6


9. Elgudin L, Hall Y, Schubert D. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.


10. Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Epilepsia. 2003 Feb;44(2):268.


11. Ziyeh S, Thiel T, Spreer J, Klisch J, Schumacher M. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.


12. Barrueto F, Hack JB. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.


13. Miyamoto T, Miyamoto M, Hirata K, Katayama S. A case report of valproate encephalopathy.


14. Hantson P, Grandin C, Duprez T, Nassogne MC, Guerit JM. Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma. Eur Radiol. 2005 Jan;15(1):59-64.


15. Kimmel RJ, Irwin SA, Meyer JM. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting. Int Clin Psychopharmacol. 2005 Jan;20(1):57-8.


16. Nakazato Y, Ando S, Yamamoto T, Tamura N, Shimazu K. Valproate-induced hyperammonemic encephalopathy in a patient with Sjogren's syndrome. Rinsho Shinkeigaku. 2004 Oct;44(10):682-5.


17. Grubben B, De Jonghe P, Cras P, Demey HE, Parizel PM. Valproate-induced hyperammonemic encephalopathy: imaging findings on diffusion-weighted MRI. Eur Neurol. 2004;52(3):178-81.


18. Yehya N, Saldarini CT, Koski ME, Davanzo P. Valproate-induced hyperammonemic encephalopathy. J Am Acad Child Adolesc Psychiatry. 2004 Aug;43(8):926-7.


19. Reif A, Leonhard C, Mossner R, Lesch KP, Fallgatter AJ. Encephalopathy and myoclonus triggered by valproic acid. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Sep;28(6):1061-3.


20. Lokrantz CM, Eriksson B, Rosen I, Asztely F. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam. Acta Neurol Scand. 2004 Apr;109(4):297-301.


21. Murphy JV. Valproate-induced hyperammonemic encephalopathy.Epilepsia. 2003 Feb;44(2):268.


22. O'Neill M, Dubrey RW, Grocott-Mason RM. Valproate encephalopathy and hyperammonaemia. Postgrad Med J. 2002 May;78(919):316-7.


23. Vainstein G, Korzets Z, Pomeranz A, Gadot N. Deepening coma in an epileptic patient: the missing link to the urea cycle. Hyperammonaemic metabolic encephalopathy. Nephrol Dial Transplant. 2002 Jul;17(7):1351-3.


24. Schwarz S, Georgiadis D, Schwab S, Gehlen F, Mayatepek E, Zoubaa S. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy. J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):90-1.


25. Lee SA, Lee JK, Heo K. Coma probably induced by lorazepam-valproate interaction. Seizure. 2002 Mar;11(2):124-5.


26. Vossler DG, Wilensky AJ, Cawthon DF, Kraemer DL, Ojemann LM, Caylor LM, Morgan JD. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.


27. Chen WT, Yen DJ, Yu HY, Liao KK. Valproate-induced encephalopathy. Zhonghua Yi Xue Za Zhi (Taipei). 2001 Aug;64(8):474-8.


28. Kifune A, Kubota F, Shibata N, Akata T, Kikuchi S. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves. Epilepsia. 2000 Jul;41(7):909-12.


29. Capocchi G, Balducci A, Cecconi M, Pelli MA, Picchiarelli A, Silvestrelli G, Zampolini M. Valproate-induced epileptic tonic status. Seizure. 1998 Jun;7(3):237-41.


30. Oechsner M, Steen C, Sturenburg HJ, Kohlschutter A. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry. 1998 May;64(5):680-2.


31. Lerman-Sagie T, Watemberg N, Kramer U, Shahar E, Lerman P. Absence seizures aggravated by valproic acid. Epilepsia. 2001 Jul;42(7):941-3.


32. Sobaniec-Lotowska ME. Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate. Int J Exp Pathol. 2001 Dec;82(6):337-48.


33. Sobaniec-Lotowska M, Sobaniec W, Augustynowicz A. Morphometric analysis of the cerebellar cortex capillaries in the course of experimental valproate encephalopathy and after chronic exposure to sodium valproate using transmission electron microscopy. Folia Neuropathol. 2001;39(4):277-80.


34. Sobaniec-Lotowska ME. Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal. Int J Exp Pathol. 2003 Jun;84(3):115-25.